VRCDFVERICI DX PLC

About VERICI DX PLC (VRCDF)

VERICI DX PLC (VRCDF) is a Diagnostics & Research company headquartered in Cardiff, United Kingdom whose shares trade over-the-counter on the Pink tier.

Verici Dx is a developer of advanced clinical diagnostics in organ transplant. Verici Dx kidney transplant assays are developed using next-generation sequencing science and leverages access to deep clinical insights derived from immunological, transcriptomic, clinical, and pathological data to define a personalized, precise risk-profile related to risk and diagnosis of kidney injury and graft loss for each patient over the course of their transplant journey.

VRCDF key facts

Ticker symbol

VRCDF

Market tier

Pink

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Cardiff, United Kingdom

Estimated market cap

$4.25M (as of May 14, 2025)

Shares outstanding

141,747,816

Reporting standard

International Reporting: LSE - London Stock Exchange

Audit status

Not Available

Fiscal year end

12/31

Explore more: Diagnostics & Research stocks · Healthcare sector · Pink stocks · OTC stocks starting with V